Get the Daily Brief
Latest Biotech News
Nuclidium Raises $98M Series B to Advance Copper-Based Radiotheranostics
Swiss-German radiopharmaceutical company Nuclidium closed a $98 million Series B financing to accelerate development and production of its copper-61 and copper-67 radiotheranostic agents for...
Biotx AI Uses GWAS Data for Drug Target Discovery and Repurposing
German startup Biotx AI leverages a vast curated genome-wide association study (GWAS) dataset with phenotypic and drug molecule data to predict disease causality and identify optimal drug targets....
Large-Scale Neurodegeneration Proteomics Consortium Identifies Biomarkers and Mechanisms
The Global Neurodegeneration Proteomics Consortium (GNPC) released one of the largest proteomic datasets comprising approximately 250 million protein measurements from over 35,000 biosamples....
CalPERS Switches Pharmacy Benefit Manager to CVS Caremark for 587,000 Members
California Public Employees’ Retirement System (CalPERS) has signed a five-year contract with CVS Caremark to provide outpatient prescription drug benefits for approximately 587,000 members...
Sarepta restructures and adds black box warning on Duchenne therapy
Sarepta Therapeutics is undergoing a major restructuring by laying off approximately 500 employees, about 36% of its workforce, and pausing research on several gene therapy programs for...
Hengrui and Kailera’s dual agonist shows strong obesity trial results in China
Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics announced promising Phase 3 results for their injected glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide...
FDA scrutiny and advisory for GSK's multiple myeloma drug Blenrep
The US Food and Drug Administration has raised safety concerns regarding GSK's antibody-drug conjugate Blenrep (belantamab mafodotin) for multiple myeloma patients, focusing on ocular toxicities...
Merck expands respiratory portfolio with Verona Pharma acquisition
Merck & Co. has acquired Verona Pharma for $10 billion, securing rights to Ohtuvayre, a novel respiratory drug approved in 2024 for chronic obstructive pulmonary disorder (COPD). The drug relaxes...
Advances in neurodegeneration proteomics reveal disease mechanisms and biomarkers
The Global Neurodegeneration Proteomics Consortium (GNPC) published findings from one of the largest proteomic datasets, comprising approximately 250 million unique protein measurements from over...
New AI and computational platforms boost biomanufacturing optimization
Researchers and industry leaders are advancing biomanufacturing through agentic AI and digital twin technologies to overcome current limitations. Systems like SIC (sense, infer, and control)...
FDA tightens oversight amid staffing cuts and controversial decisions
The FDA faces significant staffing challenges with over 380 departures at the Center for Drug Evaluation and Research between January and June 2025, alongside minimal new hires. This attrition...
Open-source molecular diagnostics improve testing accessibility in low-resource areas
International scientists developed an affordable, lyophilized reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for pathogen detection aimed at resource-limited...
LaNova Medicines acquired by Sino Biopharmaceutical for nearly $951 million
China-based Sino Biopharmaceutical has completed the acquisition of the remaining 95.09% stake in LaNova Medicines, valuing the deal at approximately $951 million, including the cash and deposits...
Breakthrough research in plant molecular biology and genomics
Recent studies have advanced understanding of gene regulation and systemic signaling in plants, including a mobile transcription factor coordinating nitrogen deficiency responses across plant...
Micro-CT Scans May Damage Fossil Integrity
A new study published in Radiocarbon reveals that micro-computerized tomography (micro-CT), a widely used technique believed to be non-destructive, may actually impact the preservation of fossils....
Miniaturized Bioreactors Employ Magnetic Levitation Stirring
At the Bioprocess Engineering 2025 meeting in Bremen, researchers from Zurich University of Applied Sciences and Levitronix presented a novel benchtop bioreactor that uses magnetic levitation for...
Cell-Free Therapies Offer Scalable Heart Attack Treatment Alternatives
Researchers highlight the manufacturing challenges that impede cell therapies for heart attack and propose 'cell-free' approaches using proteins and secretomes as easier-to-make alternatives....
Advances in Digital Twins Enhance Biomanufacturing Process Control
A team led by Dr. Moo Sun Hong at Seoul National University is optimizing digital twin models for end-to-end biomanufacturing by leveraging eight years of data sets collected originally at MIT....
Agentic AI to Revolutionize Autonomous Biomanufacturing Control
Researchers from the Technical University of Denmark and industry partners, including Novo Nordisk and SiC Systems, have developed an integrated agentic AI platform called SIC that autonomously...
Johnson & Johnson Posts $15B Pharma Sales, Offsets Stelara Losses
Johnson & Johnson reported $15.2 billion in Q2 pharmaceutical sales, surpassing $15 billion for the first time despite a 43% decline in Stelara revenue due to biosimilar competition. Growth in...